Zepp Health Projects 70% to 79% Revenue Growth in Q3, Highlighting Strong Product Momentum
Reuters
Aug 04
<a href="https://laohu8.com/S/ZEPP">Zepp Health</a> Projects 70% to 79% Revenue Growth in Q3, Highlighting Strong Product Momentum
Zepp Health Corporation has reported its financial results, highlighting a significant year-over-year revenue growth. The company projects its revenue for the third quarter to be between $72 million and $76 million, representing a 70% to 79% increase compared to the same period last year. This growth is attributed to strong execution and the positive market reception of recent product launches. Additionally, the company uses adjusted net income, a non-GAAP measure, to evaluate its performance, which excludes several factors such as share-based compensation expenses and amortization of intangible assets. This financial measure provides a clearer view of the company's operational performance without certain non-recurring expenses and gains.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zepp Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CN43178) on August 04, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.